CIK 0001447028
- Non-accelerated filer
- Smaller reporting company
Arbutus Biopharma Corp
Sign in to watch- Ticker
- ABUS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- Operating
- EIN
- 980597776
- Phone
- +1 604-419-3200
- Business address
- 701 VETERANS CIRCLE, WARMINSTER, PA, 18974
- Former names
- TEKMIRA PHARMACEUTICALS CORP, TEKMIRA PHARMACEUTICALS Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-14 | HASTINGS DAVID C Chief Financial Officer | Grant or award | +90,100 | 249,824 | ||
| 2025-02-14 | HASTINGS DAVID C Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +365,800 | 365,800 | ||
| 2025-02-04 | HASTINGS DAVID C Chief Financial Officer | Sale 10b5-1 | −22,183 | $3.28 | $73K | 159,724 |
| 2024-02-02 | HASTINGS DAVID C Chief Financial Officer | Sale 10b5-1 | −9,593 | $2.31 | $22K | 181,907 |
| 2024-02-01 | HASTINGS DAVID C Chief Financial Officer | Grant or award 10b5-1 | +112,500 | 191,500 | ||
| 2024-02-01 | HASTINGS DAVID C Chief Financial Officer | Grant or award · Stock Option (Right to Buy) 10b5-1 | +450,000 | 450,000 | ||
| 2023-02-01 | HASTINGS DAVID C Chief Financial Officer | Grant or award | +79,000 | 79,000 | ||
| 2023-02-01 | HASTINGS DAVID C Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +316,000 | 316,000 | ||
| 2022-01-20 | HASTINGS DAVID C Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +285,000 | $2.81 | $801K | 285,000 |
| 2021-02-13 | HASTINGS DAVID C Chief Financial Officer | Grant or award · Stock Options | +250,000 | 250,000 | ||
| 2020-02-17 | HASTINGS DAVID C Chief Financial Officer | Grant or award · Stock Options | +100,000 | 100,000 | ||
| 2019-03-01 | HASTINGS DAVID C Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +137,500 | 137,500 | ||
| 2018-06-19 | HASTINGS DAVID C Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +200,000 | 200,000 |
Page 1 of 1 · 13 trades